Article thumbnail

A combination of CSF tau ratio and midsaggital midbraintopons atrophy for the early diagnosis of progressive supranuclear palsy

By Barbara Borroni, Matteo Malinverno, Fabrizio Gardoni, Mario Grassi, Lucilla Parnetti, Chiara Agosti, Antonella Alberici, Enrico Premi, Ubaldo Bonuccelli, Roberto Gasparotti, Paolo Calabresi, Monica Di Luca and Alessandro Padovani

Abstract

Cerebrospinal fluid (CSF) tau ratio decrease (33kDa/55kDa forms) and mid-saggital midbrain-to-pons (MP) atrophy have been suggested as diagnostic markers for progressive supranuclear palsy (PSP). The usefulness of their combined evaluation has never been tested. We evaluated the CSF tau ratio and the MP atrophy as a combined marker for early identification of PSP. A total of 87 subjects, namely 18 PSP, 25 controls (CON), 16 corticobasal syndrome (CBS), and 28 frontotemporal dementia (FTD), were included. Each subject underwent a lumbar puncture and a conventional MRI scan to assess CSF tau 33 kDa/55 kDa ratio and mid-saggital MP measure, respectively. CSF tau ratio and MP ratio were significantly reduced in PSP patients when compared to CON, CBS, and FTD (p< 0.001). Data-based "optimal" combination of CSF tau ratio and MP measure was defined, and the combined marker TrMp= sqrt[3]CSF Tau ratio × MP ratio was considered. Considering the combined marker, the difference between the area under the curve (dAUC) of the receiver operating characteristic analysis in PSP versus the various subgroups was higher by about 10% than that obtained by each marker individually. In PSP versus others, a proposed "best" cut-off of TrMP = 0.182 resulted in 94.2% sensitivity and 84.0% specificity. When patients with onset of symptoms ≤ 2 years were included, TrMP resulted significantly decreased in PSP compared to CBS (p< 0.001) and FTD (p< 0.001). The combined marker increases the discriminative power in identifying PSP and suggests that the interplay of different markers should be considered in future trials to enhance diagnostic accuracy from the early stages. © 2010 IOS Press and the authors. All rights reserved

Topics: Biological marker, cerebrospinal fluid, corticobasal syndrome, frontotemporal dementia, MRI, progressive supranuclear palsy, tau, Aged, Atrophy, Basal Ganglia Diseases, Biomarkers, Diagnosis, Differential, Early Diagnosis, Female, Frontotemporal Dementia, Humans, Male, Mesencephalon, Middle Aged, Neuropsychological Tests, Pons, Supranuclear Palsy, Progressive, tau Proteins, Psychiatry and Mental Health, Geriatrics and Gerontology, Clinical Psychology
Publisher: 'IOS Press'
Year: 2010
DOI identifier: 10.3233/JAD-2010-100333
OAI identifier: oai:arpi.unipi.it:11568/803596
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://hdl.handle.net/11568/80... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.